SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals informs about loss of original share certificates

17 Jan 2024 Evaluate

Fredun Pharmaceuticals has informed that the Company has received intimation on January 15, 2023 from Purva Share Registry (India), the Share Transfer Agent of the Company, pertaining to loss/ misplacement of Original Share Certificate(s) and have requested for issuance of Duplicate Share Certificate(s); in lieu of their Original Share Certificates been lost. Details of the shareholder and share certificate are enclosed.

The above information is a part of company’s filings submitted to BSE.


Fredun Pharma Share Price

2087.00 43.10 (2.11%)
22-Apr-2026 09:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1658.00
Dr. Reddys Lab 1211.40
Cipla 1223.90
Zydus Lifesciences 922.75
Lupin 2288.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×